Surgery is not superior to dilation for the management of vaginal agenesis in Mayer-Rokitansky-Küster-Hauser syndrome: a multicenter comparative observational study in 131 patients


      Vaginal agenesis in Mayer-Rokitansky-Küster-Hauser syndrome can be managed either by various surgeries or dilation. The choice still depends on surgeon’s preferences rather than on quality comparative studies and validated protocols.


      We sought to compare dilation and surgical management of vaginal agenesis in Mayer-Rokitansky-Küster-Hauser syndrome, in terms of quality of life, anatomical results, and complications in a large multicenter population.

      Study Design

      Our multicenter study included 131 patients >18 years, at least 1 year after completing vaginal agenesis management. All had an independent gynecological evaluation including a standardized pelvic exam, and completed the World Health Organization Quality of Life instrument (general quality of life) as well as the Female Sexual Function Index and Female Sexual Distress Scale-Revised (sexual quality of life) scales. Groups were: surgery (N = 84), dilation therapy (N = 26), and intercourse (N = 20). One patient was secondarily excluded because of incomplete surgical data. For statistics, data were compared using analysis of variance, Student, Kruskal-Wallis, Wilcoxon, and Student exact test.


      Mean age was 26.5 ± 5.5 years at inclusion. In all groups, World Health Organization Quality of Life scores were not different between patients and the general population except for lower psychosocial health and social relationship scores (which were not different between groups). Global Female Sexual Function Index scores were significantly lower in the surgery and dilation therapy groups (median 26 range [2.8–34.8] and 24.7 [2.6–34.4], respectively) than the intercourse group (30.2 [7.8–34.8], P = .044), which had a higher score only in the satisfaction dimension (P = .004). However, the scores in the other dimensions of Female Sexual Function Index were not different between groups. The Female Sexual Distress Scale-Revised median scores were, respectively, 17 [0–52], 20 [0–47], and 10 [10–40] in the surgery, dilation therapy, and intercourse groups (P = .38), with sexual distress in 71% of patients. Median vaginal depth was shorter in dilatation therapy group (9.6 cm [5.5–12]) compared to surgery group (11 cm [6–15]) and intercourse group (11 cm [6–12.5]) (P = .039), but remained within normal ranges. One bias in the surgery group was the high number of sigmoid vaginoplasties (57/84, 68%), but no differences were observed between surgeries. Only 4 patients achieved vaginas <6.5 cm. Delay between management and first intercourse was 6 months (not significant). Seventy patients (53%) had dyspareunia (not significant), and 17 patients all from the surgery group had an abnormal pelvic exam. In the surgery group, 34 patients (40.5%) had complications, requiring 20 secondary surgeries in 17 patients, and 35 (42%) needed postoperative dilation. In the dilation therapy group, 13 (50%) needed maintenance dilation.


      Surgery is not superior to therapeutic or intercourse dilation, bears complications, and should therefore be only a second-line treatment. Psychological counseling is mandatory at diagnosis and during therapeutic management.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Gargollo P.C.
        • Cannon G.M.
        • Diamond D.A.
        • et al.
        Should progressive perineal dilation be considered first line therapy for vaginal agenesis?.
        J Urol. 2009; 182: 188-191
        • Edmonds D.K.
        • Rose G.L.
        • Lipton M.G.
        • et al.
        Mayer-Rokitansky-Küster-Hauser syndrome: a review of 245 consecutive cases managed by a multidisciplinary approach with vaginal dilators.
        Fertil Steril. 2012; 97: 68-90
      1. Aplasies utéro-vaginales, protocole national de diagnostic et de soins pour les maladies rares. Available at: Accessed July 17 2017.

        • ACOG Committee on Adolescent Health Care
        Mullerian agenesis: diagnosis, management, and treatment. ACOG Committee opinion no. 728.
        Obstet Gynecol. 2018; 131: e35-e42
        • Zhao X.W.
        • Ma J.Y.
        • Wang Y.X.
        • et al.
        Laparoscopic vaginoplasty using a single peritoneal flap: 10 years of experience in the creation of a neovagina in patients with Mayer-Rokitansky-Küster-Hauser syndrome.
        Fertil Steril. 2015; 104: 241-247
        • Callens N.
        • Weyers S.
        • Monstrey S.
        • et al.
        Vaginal dilation treatment in women with vaginal hypoplasia: a prospective one-year follow-up study.
        Am J Obstet Gynecol. 2014; 211: 228.e1-228.e12
        • Lloyd J.
        • Crouch N.S.
        • Minto C.L.
        • et al.
        Female genital appearance: “normality” unfolds.
        BJOG. 2005; 112: 643-646
        • Ismail-Pratt I.S.
        • Bikoo M.
        • Liao L.M.
        • et al.
        Normalization of the vagina by dilator treatment alone in complete androgen insensitivity syndrome and Mayer-Rokitansky-Küster-Hauser syndrome.
        Hum Reprod. 2007; 22: 2020-2024
        • D'Alberton F.
        • Assante M.T.
        • Foresti M.
        • et al.
        Quality of life and psychological adjustment of women living with 46,XY differences of sex development.
        J Sex Med. 2015; 12: 1440-1449
        • Fliegner M.
        • Krupp K.
        • Brunner F.
        • et al.
        Sexual life and sexual wellness in individuals with complete androgen insensitivity syndrome (CAIS) and Mayer-Rokitansky-Küster-Hauser syndrome (MRKHS).
        J Sex Med. 2014; 11: 729-742
        • Callens N.
        • De Cuypere G.
        • De Sutter P.
        • et al.
        An update on surgical and non-surgical treatments for vaginal hypoplasia.
        Hum Reprod Update. 2014; 20: 77-801
        • Carrard C.
        • Chevret-Measson M.
        • Lunel A.
        • et al.
        Sexuality after sigmoid vaginoplasty in patients with Mayer-Rokitansky-Küster-Hauser syndrome.
        Fertil Steril. 2012; 97 (69-6)
        • Baumann C.
        • Erpelding M.-L.
        • Régat S.
        • et al.
        The WHOQOL-BREF questionnaire: French adult population norms for the physical health, psychological health and social relationship dimensions.
        Rev Epidemiol Sante Publique. 2010; 58: 33-39
        • Kimberley N.
        • Hutson J.M.
        • Southwell B.R.
        • et al.
        Well-being and sexual function outcomes in women with vaginal agenesis.
        Fertil Steril. 2011; 95: 238-241
        • Bozon M.
        At what age do women and men have their first sexual intercourse. World comparision and recent trends.
        Population and Societies. 2003; 391 ( 1-4
        • Rosen R.
        The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function.
        J Sex Marital Ther. 2000; 26: 191-208
        • Dargis L.
        • Trudel G.
        • Cadieux J.
        • et al.
        Validation of the Female Sexual Function Index (FSFI) and presentation of norms in older women.
        Sexologies. 2012; 21: 126-131
        • Bean E.J.
        • Mazur T.
        • Robinson A.D.
        Mayer-Rokitansky-Küster-Hauser syndrome: sexuality, psychological effects, and quality of life.
        J Pediatr Adolesc Gynecol. 2009; 22: 339-346
        • McQuillan S.K.
        • Grover S.R.
        Systematic review of sexual function and satisfaction following the management of vaginal agenesis.
        Int Urogynecol J. 2014; 25 (131-20)
        • Fedele L.
        • Frontino G.
        • Restelli E.
        • et al.
        Creation of a neovagina by Davydov’s laparoscopic modified technique in patients with Rokitansky syndrome.
        Am J Obstet Gynecol. 2010; 202: 33.e1-33.e6
        • Moen M.H.
        Vaginal agenesis treated by coital dilation in 20 patients.
        Int J Gynaecol Obstet. 2014; 125: 282-283
        • Willemsen W.N.
        • Kluivers K.B.
        Long-term results of vaginal construction with the use of Frank dilation and a peritoneal graft (Davydov procedure) in patients with Mayer-Rokitansky-Küster syndrome.
        Fertil Steril. 2015; 103: 220-227.e1
        • Gauthier T.
        • Lavoue A.
        • Piver P.
        • et al.
        Which neovagina reconstruction procedure for women with Mayer-Rokitansky-Küster-Hauser syndrome in the uterus transplantation era? Editorial from the French Uterus Transplantation Committee (CETUF) of CNGOF.
        J Gynecol Obstet Hum Reprod. 2018; 47: 175-176
        • Frank R.T.
        The formation of an artificial vagina without operation.
        Am J Obstet Gynecol. 1938; : 1053-1055
        • Hensle T.W.
        Editorial comment.
        J Urol. 2009; 182: 1890-1891
        • Routh J.C.
        • Laufer M.R.
        • Cannon Jr., G.M.
        • et al.
        Management strategies for Mayer-Rokitansky-Küster-Hauser related vaginal agenesis: a cost-effectiveness analysis.
        J Urol. 2010; 184: 2116-2121
        • Patel V.
        • Hakim J.
        • Gomez-Lobo V.
        • et al.
        Providers' experiences with vaginal dilator training for patients with vaginal agenesis.
        J Pediatr Adolesc Gynecol. 2018; 31: 45-47